Varonis Systems (VRNS) to Improve Microsoft 365 Data Security
https://www.zacks.com/stock/news/2215236/varonis-systems-vrns-to-improve-microsoft-365-data-security?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2215236
Jan 24, 2024 - Varonis Systems (VRNS) and Microsoft partner to enhance the data security posture of Microsoft 365 so that their shared customers can securely leverage artificial intelligence tools.
0
Salesforce.com (CRM) Is Up 3.29% in One Week: What You Should Know
https://www.zacks.com/stock/news/2214414/salesforce-com-crm-is-up-3-29-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2214414
Jan 23, 2024 - Does Salesforce.com (CRM) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Top Stock Reports for Alphabet, Salesforce & Comcast
https://www.zacks.com/commentary/2213407/top-stock-reports-for-alphabet-salesforce-comcast?cid=CS-ZC-FT-research_daily-2213407
Jan 22, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Salesforce, Inc. (CRM) and Comcast Corporation (CMCSA).
0
BOX Bolsters Box Sign Portfolio With FDA Part 11 Approval
https://www.zacks.com/stock/news/2212091/box-bolsters-box-sign-portfolio-with-fda-part-11-approval?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2212091
Jan 18, 2024 - BOX receives FDA 21 CFR Part 11 approval for electronic signatures, facilitating research, development and manufacturing processes without incurring incremental costs.
0
Salesforce (CRM) Unveils GenAI-Powered Tools for Retailers
https://www.zacks.com/stock/news/2210013/salesforce-crm-unveils-genai-powered-tools-for-retailers?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2210013
Jan 15, 2024 - Salesforce (CRM) brings generative AI to its Commerce Cloud and Marketing Cloud solutions, which is likely to help retail merchandisers optimize their business operations while enhancing shoppers' experience.
0
Are the "Magnificent Seven" Really That Great?
https://www.fool.com/investing/2024/01/13/are-the-magnificent-seven-really-that-great/?source=iedfolrf0000001
Jan 13, 2024 - We've also got a look at two stocks worth watching: UiPath and Pebblebrook Hotel Trust.
0
Infosys (INFY) Gains 4% as Q3 Earnings & Revenues Beat Estimates
https://www.zacks.com/stock/news/2209411/infosys-infy-gains-4-as-q3-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2209411
Jan 12, 2024 - Infosys' (INFY) better-than-expected Q3 performance reflects the benefits of strong sales executions and improved operational efficiencies.
0
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group
https://www.zacks.com/stock/news/2206930/the-zacks-analyst-blog-highlights-merck-salesforce-philip-morris-international-novartis-and-cme-group?cid=CS-ZC-FT-press_releases-2206930
Jan 08, 2024 - Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
0
Top Analyst Reports for Merck, Salesforce & Philip Morris
https://www.zacks.com/commentary/2206306/top-analyst-reports-for-merck-salesforce-philip-morris?cid=CS-ZC-FT-research_daily-2206306
Jan 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
0
Wall Street Analysts Think Salesforce.com (CRM) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2205636/wall-street-analysts-think-salesforce-com-crm-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2205636
Jan 04, 2024 - Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0